{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:35:45Z","timestamp":1782797745040,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Golestan University of medical sciences","doi-asserted-by":"publisher","award":["110431"],"award-info":[{"award-number":["110431"]}],"id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.diabres.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T15:38:11Z","timestamp":1557934691000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"152","author":[{"given":"Mohammad Mostakhdem","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Arab-Bafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Nezhadebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoljalal","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.05.007_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10528-010-9376-6","article-title":"PON1 55 and 192 gene polymorphisms in type 2 diabetes mellitus patients in a Turkish population","volume":"49","author":"Ergun","year":"2011","journal-title":"Biochem Genet"},{"key":"10.1016\/j.diabres.2019.05.007_b0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.dsx.2012.02.009","article-title":"The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions","volume":"5","author":"Marjani","year":"2011","journal-title":"Diabet Metabolic Syndrome: Clin Res Rev"},{"key":"10.1016\/j.diabres.2019.05.007_b0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/jcmm.13453","article-title":"European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus","volume":"22","author":"Luo","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.diabres.2019.05.007_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(98)00064-7","article-title":"Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification","volume":"423","author":"Mackness","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.diabres.2019.05.007_b0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1996.0225","article-title":"The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family","volume":"33","author":"Primo-Parmo","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.diabres.2019.05.007_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2019.05.007_b0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinchem\/32.4.671","article-title":"Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction","volume":"32","author":"McElveen","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2019.05.007_b0040","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0748233711399317","article-title":"The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients","volume":"27","author":"Altuner","year":"2011","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.diabres.2019.05.007_b0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clinbiochem.2010.12.019","article-title":"Are PON1 Q\/R 192 and M\/L 55 polymorphisms risk factors for diabetes complications in Turkish population?","volume":"44","author":"Altuner","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.diabres.2019.05.007_b0050","first-page":"1647","article-title":"Age-related alterations of plasma lipid peroxidation and erythrocyte superoxide dismutase activity in different age groups of Gorgan City, Iran","volume":"26","author":"Marjani","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.diabres.2019.05.007_b0055","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1161\/01.ATV.17.12.3565","article-title":"A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese","volume":"17","author":"Zama","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2019.05.007_b0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2001-14836","article-title":"Paraoxonase 1 192 Gln\/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes","volume":"109","author":"Koch","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.diabres.2019.05.007_b0065","first-page":"598","article-title":"Molecular basis for the polymorphic forms of human serum paraoxonase\/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes","volume":"52","author":"Adkins","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.diabres.2019.05.007_b0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI119134","article-title":"Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes","volume":"99","author":"Garin","year":"1997","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabres.2019.05.007_b0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00008571-199912000-00009","article-title":"Determination of paraoxonase (PON1) status requires more than genotyping","volume":"9","author":"Richter","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.diabres.2019.05.007_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-60761-350-3_4","article-title":"Paraoxonase 1 status as a risk factor for disease or exposure","author":"Richter","year":"2010","journal-title":"Paraoxonases Inflammation, Infect, Toxicol Springer"},{"key":"10.1016\/j.diabres.2019.05.007_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.fpc.0000189796.21770.d3","article-title":"PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity","volume":"16","author":"Furlong","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.diabres.2019.05.007_b0090","first-page":"147","article-title":"Determination of paraoxonase 1 status without the use of toxic organophosphate substrates","volume":"1","author":"Richter","year":"2008","journal-title":"Circulation: Genomic Precision Med"},{"key":"10.1016\/j.diabres.2019.05.007_b0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj3040549","article-title":"Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations","volume":"304","author":"Garin","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.diabres.2019.05.007_b0100","doi-asserted-by":"crossref","first-page":"e17805","DOI":"10.1371\/journal.pone.0017805","article-title":"Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2019.05.007_b0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbrc.2008.12.154","article-title":"Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis","volume":"379","author":"Katakami","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2019.05.007_b0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/eje.0.1440639","article-title":"Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?","volume":"144","author":"Osei-Hyiaman","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2019.05.007_b0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(95)92709-3","article-title":"Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes","volume":"346","author":"Ruiz","year":"1995","journal-title":"The Lancet"},{"key":"10.1016\/j.diabres.2019.05.007_b0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930530","article-title":"Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus","volume":"54","author":"Agachan","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.diabres.2019.05.007_b0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bjp.0701390","article-title":"Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon","volume":"122","author":"Mackness","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.diabres.2019.05.007_b0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","article-title":"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus","volume":"139","author":"Mackness","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2019.05.007_b0135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.33549\/physiolres.931285","article-title":"Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus","volume":"57","author":"Fleka\u010d","year":"2008","journal-title":"Physiol Res"},{"key":"10.1016\/j.diabres.2019.05.007_b0140","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2019.05.007_b0145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0026-0495(98)90246-3","article-title":"Serum paraoxonase activity and its relationship to diabetic complications in patients with non\u2014insulin-dependent diabetes mellitus","volume":"47","author":"Ikeda","year":"1998","journal-title":"Metabolism-Clin Exp"},{"key":"10.1016\/j.diabres.2019.05.007_b0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/22201009.2012.10872283","article-title":"Enzymatic and genetic polymorphisms of paraoxonase-1 in the Gabonese population: the relation to lipid parameters in patients with diabetes","volume":"17","author":"Abessolo","year":"2012","journal-title":"J Endocrinol, Metabol Diabet South Africa"},{"key":"10.1016\/j.diabres.2019.05.007_b0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2017.08.037","article-title":"Association between promoter polymorphism (\u2212 108C> T) of paraoxonase1 gene and it's paraoxonase activity in patients with Type2 diabetes in northern Iran","volume":"474","author":"Shakeri","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.diabres.2019.05.007_b0160","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/meta.2000.17724","article-title":"Serum arylesterase\/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes","volume":"49","author":"Inoue","year":"2000","journal-title":"Metabolism-Clin Exp"},{"key":"10.1016\/j.diabres.2019.05.007_b0165","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diabetes.49.8.1390","article-title":"Promoter polymorphism T (-107) C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients","volume":"49","author":"James","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.05.007_b0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11033-011-0819-x","article-title":"Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome","volume":"39","author":"Kordi-Tamandani","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.diabres.2019.05.007_b0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gene.2012.01.091","article-title":"Low serum PON1 activity: An independent risk factor for coronary artery disease in North-West Indian type 2 diabetics","volume":"498","author":"Gupta","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.diabres.2019.05.007_b0180","doi-asserted-by":"crossref","unstructured":"Morris SB. Book Review: Hunter, JE, Schmidt, FL. Methods of Meta-Analysis: Correcting Error and Bias in Research Findings. Thousand Oaks, CA: Sage. Organizational Research Methods. 2004;2008;11:184\u20137.","DOI":"10.1177\/1094428106295494"},{"key":"10.1016\/j.diabres.2019.05.007_b0185","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1198\/sbr.2009.0067","article-title":"Measuring study-specific heterogeneity in meta-analysis: application to an antecedent biomarker study of Alzheimer\u2019s disease","volume":"2","author":"Xiong","year":"2010","journal-title":"Statist Biopharmaceut Res"},{"key":"10.1016\/j.diabres.2019.05.007_b0190","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2011"},{"key":"10.1016\/j.diabres.2019.05.007_b0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses. BMJ","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.diabres.2019.05.007_b0200","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"1088\u2013101","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.diabres.2019.05.007_b0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj2460761","article-title":"Conformational changes induced in lens \u03b1-and \u03b3-crystallins by modification with glucose 6-phosphate. Implications for cataract","volume":"246","author":"Beswick","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.diabres.2019.05.007_b0210","doi-asserted-by":"crossref","first-page":"24207","DOI":"10.1016\/S0021-9258(18)35751-X","article-title":"Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites","volume":"267","author":"Reiser","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2019.05.007_b0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clinbiochem.2006.01.010","article-title":"Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk","volume":"39","author":"Baum","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.diabres.2019.05.007_b0220","first-page":"1742","article-title":"Paraoxonase 1 gene polymorphism relationship with type 2 diabetes mellitus","volume":"9","author":"Elattar","year":"2012","journal-title":"Life Sci J-Acta Zhengzhou Univ Ed"},{"key":"10.1016\/j.diabres.2019.05.007_b0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2019.05.007_b0230","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/bi00106a009","article-title":"Purification of rabbit and human serum paraoxonase","volume":"30","author":"Furlong","year":"1991","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.diabres.2019.05.007_b0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20040187","article-title":"Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1","volume":"107","author":"Deakin","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.diabres.2019.05.007_b0240","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0021-9150(00)00680-8","article-title":"Relationship of age-related myocardial infarction risk and Gln\/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study","volume":"156","author":"Sent\u0131","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2019.05.007_b0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1194\/jlr.P800070-JLR200","article-title":"Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes","volume":"50","author":"Connelly","year":"2009","journal-title":"J Lipid Res"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719304000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719304000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T02:16:02Z","timestamp":1663467362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719304000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":49,"alternative-id":["S0168822719304000"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.05.007","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}